Reta's Story

A Clinical Trial Gives Lung Cancer Patient New Hope

When Reta Ritondaro was diagnosed with lung cancer, the average survival for the disease was just 12 to 15 months. So when her doctor offered her the opportunity to participate in a clinical trial, she accepted, knowing that it might be her best chance for beating her cancer. Within just a few weeks of treatment, Reta’s tumor was almost completely gone; four years later, she’s still beating the odds.